Anja M. Geerts
Ghent University Hospital · 415 works · 8,305 citations · h-index 44
Top works
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
- Angiogenesis in chronic liver disease and its complications
- 90 Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆
- A global research priority agenda to advance public health responses to fatty liver disease
- Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment
- The paradox of the unfolded protein response in cancer.
- Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation
- Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
- Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: An analysis of cutoff values
- The Multicenter Belgian Survey on Liver Transplantation for Hepatocellular Failure after Bariatric Surgery
- Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation
- Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool
- Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease
- Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
- Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
- Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD
- Pathobiology of hepatic stellate cells.